Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $1.09 Million - $1.33 Million
31,564 Added 1.11%
2,885,944 $122 Million
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $1.57 Million - $1.93 Million
46,991 Added 1.67%
2,854,380 $102 Million
Q4 2022

Feb 14, 2023

BUY
$25.32 - $51.45 $2.56 Million - $5.2 Million
101,109 Added 3.74%
2,807,389 $103 Million
Q3 2022

Nov 15, 2022

BUY
$46.5 - $79.14 $2.13 Million - $3.62 Million
45,731 Added 1.72%
2,706,280 $128 Million
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $8,134 - $10,932
129 Added 0.0%
2,660,549 $191 Million
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $4.55 Million - $6.1 Million
61,351 Added 2.36%
2,660,420 $215 Million
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $7.06 Million - $8.45 Million
82,093 Added 3.26%
2,599,069 $267 Million
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $5.72 Million - $6.5 Million
67,483 Added 2.75%
2,516,976 $220 Million
Q2 2021

Aug 16, 2021

BUY
$76.44 - $89.57 $47.3 Million - $55.4 Million
619,006 Added 33.82%
2,449,493 $219 Million
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $12.4 Million - $14.8 Million
183,664 Added 11.15%
1,830,487 $139 Million
Q4 2020

Feb 16, 2021

BUY
$53.08 - $69.86 $8.79 Million - $11.6 Million
165,512 Added 11.17%
1,646,823 $112 Million
Q3 2020

Nov 10, 2020

BUY
$51.29 - $65.09 $251,064 - $318,615
4,895 Added 0.33%
1,481,311 $78.7 Million
Q2 2020

Aug 14, 2020

SELL
$34.32 - $62.43 $17.4 Million - $31.6 Million
-506,022 Reduced 25.53%
1,476,416 $86 Million
Q1 2020

May 11, 2020

BUY
$32.64 - $73.63 $64.7 Million - $146 Million
1,982,438 New
1,982,438 $78.1 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.